期刊文献+

Framework for assessing quality of care for inflammatory bowel disease in Sweden 被引量:2

Framework for assessing quality of care for inflammatory bowel disease in Sweden
下载PDF
导出
摘要 AIM: To create and apply a framework for quality assessment and improvement in care for inflammatory bowel disease (IBD) patients. METHODS A framework for quality assessment and improvement was created for IBD based on two generally acknowledged quality models. The model of Donabedian (Df) offers a logistical and productive perspective and the Clinical Value Compass (CVC) model adds a management and service perspective. The framework creates a pedagogical tool to understand the balance between the dimensions of clinical care (CVC) and the components of clinical outcome (Df). The merged models create a framework of the care process dimensions as a whole, reflecting important parts of the IBD care delivery system in a local setting. Clinical and organizational quality measures were adopted from clinical experience and the literature and were integrated into the framework. Data were collected at the yearly check-up for 481 IBD patients during 2008. The application of the quality assessment framework was tested and evaluated in a local clinical IBD care setting in Jnkping County, Sweden. RESULTS: The main outcome was the presentation of how locally-selected clinical quality measures, integrated into two complementary models to develop a frame-work, could be instrumental in assessing the quality of care delivered to patients with IBD. The selected quality measures of the framework noted less anemia in the population than previously reported, provided information about hospitalization rates and the few surgical procedures reported, and noted good access to the clinic. CONCLUSION: The applied local quality framework was feasible and useful for assessing the quality of care delivered to IBD patients in a local setting. AIM: To create and apply a framework for quality assessment and improvement in care for inflammatory bowel disease (IBD) patients. METHODS A framework for quality assessment and improvement was created for IBD based on two generally acknowledged quality models. The model of Donabedian (Df) offers a logistical and productive perspective and the Clinical Value Compass (CVC) model adds a management and service perspective. The framework creates a pedagogical tool to understand the balance between the dimensions of clinical care (CVC) and the components of clinical outcome (Df). The merged models create a framework of the care process dimensions as a whole, reflecting important parts of the IBD care delivery system in a local setting. Clinical and organizational quality measures were adopted from clinical experience and the literature and were integrated into the framework. Data were collected at the yearly check-up for 481 IBD patients during 2008. The application of the quality assessment framework was tested and evaluated in a local clinical IBD care setting in Jnkping County, Sweden. RESULTS: The main outcome was the presentation of how locally-selected clinical quality measures, integrated into two complementary models to develop a frame-work, could be instrumental in assessing the quality of care delivered to patients with IBD. The selected quality measures of the framework noted less anemia in the population than previously reported, provided information about hospitalization rates and the few surgical procedures reported, and noted good access to the clinic. CONCLUSION: The applied local quality framework was feasible and useful for assessing the quality of care delivered to IBD patients in a local setting.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第10期1085-1092,共8页 世界胃肠病学杂志(英文版)
基金 Supported by The Futurum Research Council, Jnkping County Council, the Foundation for Clinical Cancer Research in Jnkping County VINNVRD-research program for more effective and better health care
关键词 Quality measures Inflammatory bowel disease Value compass Donabedian Quality improvement 环境质量评估 临床护理 框架 鸡传染性法氏囊病 瑞典 炎症 质量模型
  • 相关文献

参考文献39

  • 1McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCris- tofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635-2645.
  • 2Siegel CA, Melmed GY, Ullman TA. Improving quality of care in IBD: a STEEEP challenge. Inflamm Bowel Dis 2010; 16: 134-136.
  • 3Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 2005; 100: 1357-1361.
  • 4Brotman M, Allen JI, Bickston SJ, Campbell DR, Huddleston JM, Peterson LE, Schoenfeld PS, Sennett CS, Willis JR. AGA Task Force on Quality in Practice: a national overview and implications for GI practice. Gastroenterology 2005; 129: 361-369.
  • 5Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discus- sion. Inflamm Bowel Dis 2010; 16: 125-133.
  • 6Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007; 133: 1670-1689.
  • 7Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis 2004; 10 Suppl 1: S32-S34.
  • 8Porter ME, Teisberg EO. How physicians can change the fu- ture of health care. JAMA 2007; 297: 1103-1111.
  • 9Institute of Medicine Committee on Quality of Health Care in America. In: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press, 2001.
  • 10Rejler M, Sp?ngéus A, Tholstrup J, Andersson-G?re B. Im- proved population-based care: Implementing patient-and demand-directed care for inflammatory bowel disease and evaluating the redesign with a population-based registry. Qual Manag Health Care 2007; 16: 38-50.

同被引文献33

  • 1Jacqueline F. De Luca,Richard Severino,Yun Sun Lee,Douglas Johnson.Dermatologist and gastroenterologist awareness of the potential of immunosuppressants used to treat inflammatory bowel disease to cause non‐melanoma skin cancer[J]. International Journal of Dermatology . 2013 (8)
  • 2Johan Burisch,Tine Jess,Matteo Martinato,Peter L. Lakatos.The burden of inflammatory bowel disease in Europe[J]. Journal of Crohn’s and Colitis . 2013
  • 3Fernando Magro,Laurent Peyrin-Biroulet,Harry Sokol,Xavier Aldeger,Antonia Costa,Peter D. Higgins,Joel C. Joyce,Konstantinos H. Kastanos,Anthony Lopez,Teresa Mas de Xaxars,Elena Toader,Laurent Beaugerie.Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)[J]. Journal of Crohn’s and Colitis . 2013
  • 4Giuseppe Costantino,Federica Furfaro,Alessandra Belvedere,Angela Alibrandi,Walter Fries.Thiopurine treatment in inflammatory bowel disease: Response predictors, safety, and withdrawal in follow-up[J]. Journal of Crohn’s and Colitis . 2011 (5)
  • 5Natalie A. Molodecky,Ing Shian Soon,Doreen M. Rabi,William A. Ghali,Mollie Ferris,Greg Chernoff,Eric I. Benchimol,Remo Panaccione,Subrata Ghosh,Herman W. Barkema,Gilaad G. Kaplan.Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review[J]. Gastroenterology . 2012 (1)
  • 6Alvita J. Chan,Julie Chan,Joseph A. Cafazzo,Peter G. Rossos,Tim Tripp,Kaveh Shojania,Tanya Khan,Anthony C. Easty.ORDER SETS IN HEALTH CARE: A SYSTEMATIC REVIEW OF THEIR EFFECTS[J]. International Journal of Technology Assessment in Health Care . 2012 (3)
  • 7Byron P.Vaughn,Glen A.Doherty,ShivaGautam,Alan C.Moss,Adam S.Cheifetz.Screening for tuberculosis and hepatitis B prior to the initiation of anti‐tumor necrosis therapy[J]. Inflamm Bowel Dis . 2012 (6)
  • 8Barrett G. Levesque,Edward V. Loftus.Initiating Azathioprine for Crohn’s Disease[J]. Clinical Gastroenterology and Hepatology . 2012 (5)
  • 9Andrew M. Ryan,Tim Doran.The Effect of Improving Processes of Care on Patient Outcomes: Evidence From the United Kingdom’s Quality and Outcomes Framework[J]. Medical Care . 2012 (3)
  • 10Remo Panaccione,Toshifumi Hibi,Laurent Peyrin-Biroulet,Stefan Schreiber.Implementing changes in clinical practice to improve the management of Crohn’s disease[J]. Journal of Crohn’s and Colitis . 2012

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部